Report
Three glaucoma patients have received experimental drug injections; no serious adverse events reported
STAT reports Life Biosciences said each patient received a single injection of its cellular reprogramming drug.
TLDR
STAT reports that Life Biosciences said on October 8 that three glaucoma patients had each received a single injection of its experimental cellular reprogramming drug, with no serious adverse events.
Combined views
1.8K
1 Source, first seen ago